THIOTHIXENE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Thiothixene Hydrochloride, and when can generic versions of Thiothixene Hydrochloride launch?
Thiothixene Hydrochloride is a drug marketed by Alpharma Us Pharms, Paco, Teva, Teva Pharms, and Hikma. and is included in six NDAs.
The generic ingredient in THIOTHIXENE HYDROCHLORIDE is thiothixene hydrochloride. There are six drug master file entries for this compound. Additional details are available on the thiothixene hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THIOTHIXENE HYDROCHLORIDE?
- What are the global sales for THIOTHIXENE HYDROCHLORIDE?
- What is Average Wholesale Price for THIOTHIXENE HYDROCHLORIDE?
Summary for THIOTHIXENE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Clinical Trials: | 4 |
Patent Applications: | 5,196 |
DailyMed Link: | THIOTHIXENE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for THIOTHIXENE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Lindner Center of HOPE | Phase 2 |
Janssen Scientific Affairs, LLC | |
Drug Safety and Effectiveness Network, Canada |